广康生化(300804.SZ)发布前三季度业绩，归母净利润3484.84万元，增长47.10%

Core Viewpoint - Guangkang Biochemical (300804.SZ) reported a revenue of 550 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 13.53% [1] - The net profit attributable to shareholders reached 34.8484 million yuan, marking a year-on-year increase of 47.10% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 32.4105 million yuan, showing a significant year-on-year growth of 169.48% [1] - The basic earnings per share stood at 0.4709 yuan [1]